References
Abbai, N. S., Ramjee, G. & Wand, H. (2013). Sexually Transmitted Infections in Women Participating in a Biomedical Trial in Durban; Prevalence, Coinfections and Risk Factors. Journal of Sexually Transmitted Disease, 2013, 1-6. Centers for Disease Control and Prevention (2006). Sexually transmitted diseases treatment guidelines 2006. Morbidity and Mortality Weekly Report, 55(RR–11), 50–54. Centers for Disease Control and prevention (2013). US Department of Health and Human Service. Antibiotic Resistance threats in the United States. Atlanta. Christine, L. H., Lahra, A., McKenna, C. E., Renee, H. & Stephen, E. H. (2017). Adverse Birth Outcome and Maternal Neisseria gonorrhoea Infection: A Population Based Cohort Study in Washington State. Sexually Transmitted Disease, 44(5), 266-271. Galimand, M., Gerbaud, G.& Courvalin, P. (2000). Spectinomycin Resistancein Neisseria spp. due to Mutations in 16S rRNA. Antimicrobial Agents and Chemotherapy, 44(5), 1365- 1366. Gerbase, A. C., Rowley, J. T. & Mertens, T. E. (1998). Global Epidemiologyof Sexually Transmitted Diseases. Lancet, 351(3), 2–4. Gill, M. J., Simjee, S., Al-Hattawi, K., Robertson, B.D., Easmon, C. S. & Ison, C. A. (1998). Gonococcal Resistance to Beta-Lactams and Tetracycline Involves Mutation in Loop 3 of the Porin encoded at the penB Locus. Antimicrobial Agents and Chemotherapy,42(11), 2799-2803. Gould, I. M. & Bal, A. M. (2013). New Antibiotic Agents in the Pipeline and how they can help Overcome Microbial Resistance.Virulence,4(2), 185-191. Gray-Owen, S. D. & Blumberg, R. S. (2006). CEACAM1: Contact-dependent control of immunity. National Review Immunology, 6(6), 433-446. Grohman, E. Muth, G. & Espinosa, M. (2003). Conjugative Plasmid Transfer in Gram-Positive Bacteria. Microbiology of Molecular Biology Review, 67, 277-301. Hafeez, C. A. & Aslam, M. (2016). Prevalence and Antimicrobial Susceptibility of Methicillin Resistant Staphylococcus aureus . Journal of Clinical and Diagnostic Research,57, 245-232. Han, X. Y., Hong, T. & Falsen, E. (2006). Neisseria bacilliformis specie. Nov. Isolate from Human Infections. Journal for Clinical Microbiology, 44, 474-479. Hay, P., Lamont, R., Taylor-Robinson, D., Morgan, D., Ison, C. & Pearson, J. (1994). Abnormal Bacterial Colonisation of the Genital Tract and Subsequent Preterm Delivery and Late Miscarriage. British Medical Journal, 308(6924), 295. Hiramatsu, K. (1995). Molecular Evolution of MRSA. Microbiology Immunology, 39,531-543. Hiramatsu, K. (2001). Vancomycin-Resistant Staphylococcus aureus: A New Model of Antibiotic Resistance. Lancet Infectious Disease, 1, 147-155. Hiramatsu, K., Hanaki, H.,Ino, T., Yabuta, K., Oguri, T. & Tenover, F. (1997). Methicillin- Resistant Staphylococcus aureus Clinical Strain with Reduced Vancomycin Susceptibility. Journal of Antimicrobial Chemotherapy,40, 135-136. Johnson, H. L., Ghanem, K. G., Zenilman, J. M. & Erbelding, E. (2011). Sexually Transmitted Infections and Adverse Pregnancy Outcomes among Women Attending Inner City Public Sexually Transmitted Diseases Clinics. Sexually Transmitted Diseases, 38, 167- 171. Kirkcaldy, R. D., Weston, E., Segurado, A. C., & Hughes, G. (2019): Epidemiology of gonorrhoea: a global perspective. Sex Health. 16(5),401-411. doi: 10.1071/SH19061. Kristen, K., Elizabeth, T., Kyle, B., Jaeyoung, H. & Rachel, G. (2017). Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age- United State 2013-2014, Morbidity and Mortality Weekly Report, 66(3), 80-83. Liu, B., Roberts, C., Clarke, M., Jorm, L., Hunt, J. & Ward, J. (2013). Chlamydia and gonorrhoeae Infections and the Risk of Adverse Obstetric Outcomes. A Retrospective Cohort Study. Sexually Transmitted Infections, 89(8), 672-678. Mlisana, K., Naicker, N., Werner, L., Robert, L., Loggerenberg, F., Baxter, C., Passmore, J., Grobler, A., Sturm, A., Williamson, C., Ronacher, K., Walzi, G. & Karim, S. (2012). Symptomatic Vaginal Discharge is a Poor Predictor of Sexually Transmitted Infections and Genital Tract Inflammation in High Risk Women in South African. Journal of Infectious Disease, 206(1), 6-14. Muhammad, I., Golparian, D., Dillon, J. A., Johansson, A., Ohnishi, M., Sethi, S., Chen, S., Nakayama, S., Sundqvist, M., Bala, M. & Unemo, M. (2014). Characterisation of blaTEM Genes and Types ofbeta-lactamase Plasmids in Neisseria gonorrhoea the Prevalent and Conserved blaTEM-135 has not recently evolved andexisted in the Toronto Plasmid from the origin. BMC Infectious Diseases,14, 454. Mumtaz, S., Ahmad, M., Aftab, I., Akhtar, N., Hassan, M. & Hamid, A. (2008). Aerobic Vaginal Pathogens and their sensitivity Pattern. Journal of Ayub College Abbottabad,20 (1), 113-117. Murta, E. F., Silva, A. O., Silva, E. A. & Adad, S. J. (2005). Frequency of Infectious Agents for Vaginitis in Non-Hysterectomized and Hysterectomized Women. Archives of Gynaecology and Obstetrics, 273(3), 152–156. Myer, L., Denny, L., Telerant, R., De Souza, M., Wright Jr., T. & Kuhn, L. (2005). Bacterial Vaginosis and Susceptibility to HIV Infection in South African women: A Nested Case- Control Study. Journal of Infectious Diseases, 192(8), 1372–1380. Pourabbas, B., Rezaei, Z., Mardaneh, J., Shahran, M. & Alborzi, A. (2018). Prevalence of Chlamydia trachomatis and Neisseria gonorrheainfections among Pregnant Women and Eye Colonization of their Neonates at Birth Time, Shraz, Southern Iran II Medical and Health Science 1117 Public Health and Health Services, BMC Infectious Disease,18(1), 1-4. Roberta, B., Kevin, E., David, E., Sharon, H., Carol A., Richard L., Peter, R. & Holley, E. (2005). Bacterial vaginosis (BV) and the Risk of Incident gonococcal or ChlamydialGenital Infection in a Predominantly Black Population. Sexually Transmitted Disease, 32(7), 413-417. Tanaka, M., Takahashi, K., Saika, T., Kobayashi, I., Ueno, T. & Kumazawa, J. (1998). Development of Fluoroquinolone Resistance andMutations Involving GyrA and ParC Proteins among Neisseria gonorrhoeae isolates in Japan. Journal of Urology,159(6), 2215-2219. Todar, K. (2011). Bacterial Resistance to Antibiotics. In Todar’s online textbook of bacteriology. Available from: http://www. Textbookofbacteriology.net/resantimicrobial.html [Last accessed on 2011 Jul 21]. Unemo, M. (2015). Current and Future Antimicrobial Treatment of gonorrhoea the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infectious Diseases, 15, 364. Unemo, M. & Shafer, W. M. (2011). Antibiotic Resistance in Neisseria gonorrhoeae: Origin, Evolution, and Lessons Learned for the Future. Annals of the New York Academy of Sciences, 1230, 19-28. Unemo, M. & Shafer, W. M. (2014). Antimicrobial Resistance in Neisseria gonorrhea in the 21st century: Past, Evolution and Future, Clinical Microbiology Reviews, 27(3), 587- 613. Unemo, M., Golparian, D. & Hellmark, B. (2014). First three N. gonorrhoeae isolates with high level resistance to Azithromycin in Sweden: a threat to currently available dual antimicrobial regimens for treatment of gonorrhoea? Antimicrobial Agents and chemotherapy, 58(1), 624-625. Veal, W. L., Nicholas, R. A.& Shafer, W. M. (2002). Overexpression of the MtrCMtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Journal of Bacteriology, 184(20), 5619-5624. Wondemagegn, M., Yimer, M., Zenebe, Y. & Abera, B. (2015). Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study. BMC Women’s Health, 15(42), 1–9. World Health Organisation (2014). Human Reproductive Programme. Sexually Transmitted Infections. Fact Sheet. World Health Organisation (2016). WHO Guidelines for the Treatment of Neisseria gonorrhoeae. World Health Organisation (2016). UN Adhoc Interagency Coordinating group on Antimicrobial resistance. New report calls for urgent action to avert antimicrobial resistance crisis. United Nations. Zarantonelli, L., Borthagaray, G., Lee, E.H., & Shafer, W. M. (1999). Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrobial Agents and Chemotherapy, 43(10), 2468-2472.